Related Experiment Videos
Molsidomine and lipid metabolism
1Laboratoires Hoechst, Paris, France.
Journal of Cardiovascular Pharmacology
|January 1, 1989
Summary
Molsidomine treatment in angina patients significantly lowered cholesterol and triglycerides. Further research is needed to confirm molsidomine
Area of Science:
- Cardiology
- Pharmacology
- Lipid Metabolism
Background:
- Angina pectoris affects millions globally, necessitating effective treatments.
- Current antianginal therapies aim to improve symptoms and cardiovascular outcomes.
- Understanding drug effects on lipid profiles is crucial for comprehensive patient care.
Purpose of the Study:
- To evaluate the effects of molsidomine on lipid metabolism in patients with angina.
- To assess changes in total cholesterol, triglycerides, and apolipoproteins during molsidomine treatment.
Main Methods:
- A 12-month postmarketing surveillance study.
- Involved 3,757 patients with chronic stable angina or angina at rest.
- Patients received molsidomine alone or with other antianginal drugs.
Main Results:
- Significant reductions observed in total cholesterol, triglycerides, and apolipoprotein B.
- The apolipoprotein B/A1 ratio also showed a significant decrease.
- No significant changes were noted in apolipoprotein A1 levels.
Conclusions:
- Molsidomine demonstrated a potential favorable impact on lipid metabolism.
- Further investigation is warranted to elucidate the precise mechanisms and clinical significance.
- These findings suggest a possible pleiotropic effect of molsidomine beyond its antianginal properties.